---
title: "European stocks \"Eleven Arhats\" closing report | Novo Nordisk rose over 6.4%, Roche rose 3.5%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/265384124.md"
description: "On November 11th, Novo Nordisk's stock price rose by 6.43%, closing at 313.70 Danish Krone, while ASM Holdings increased by 0.02%, closing at 886.90 Euros. Roche Pharmaceuticals rose by 3.51%. Deutsche Bank lowered its price target for Novo Nordisk and reported that the company has reduced the price of the weight loss drug Wegovy by up to 33% in the Indian market. Other companies such as GlaxoSmithKline, AstraZeneca, Sanofi, LVMH, and Nestlé also experienced varying degrees of increase"
datetime: "2025-11-11T17:23:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/265384124.md)
  - [en](https://longbridge.com/en/news/265384124.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/265384124.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/265384124.md) | [繁體中文](https://longbridge.com/zh-HK/news/265384124.md)


# European stocks "Eleven Arhats" closing report | Novo Nordisk rose over 6.4%, Roche rose 3.5%

On Tuesday (November 11), ASML Holding's stock price in Amsterdam (ASML.NA) rose by 0.02%, closing at €886.90. Novo Nordisk's stock price in Copenhagen (NOVOB.DC) increased by 6.43%, closing at 313.70 Danish Krone. Deutsche Bank lowered its price target for the company, and Reuters reported that the company reduced the price of its weight loss drug Wegovy in the Indian market—by as much as 33%. Roche's stock rose by 3.51%, GlaxoSmithKline, AstraZeneca, Sanofi, LVMH, and Nestlé increased by up to 2.96%, Novartis rose by 1.84%, and L'Oréal and SAP increased by up to 0.78%

### Related Stocks

- [Roche Holding AG (RHHBY.US)](https://longbridge.com/en/quote/RHHBY.US.md)
- [Novo Nordisk A/S (NVO.US)](https://longbridge.com/en/quote/NVO.US.md)

## Related News & Research

- [Novo Nordisk A/S $NVO Shares Purchased by Heirloom Wealth Management](https://longbridge.com/en/news/281345767.md)
- [Novo Nordisk A/S Approves Board Changes](https://longbridge.com/en/news/280694583.md)
- [GSK says bepirovirsen accepted for review in China](https://longbridge.com/en/news/280965183.md)
- [Novo Nordisk slashes Wegovy prices to court uninsured patients](https://longbridge.com/en/news/281206892.md)
- [Novo Nordisk Seeks to Expand Reach of Weight Loss Drug in Japan](https://longbridge.com/en/news/279766298.md)